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2Abstract
Mammalian genomic imprinting is regulated by Imprinting Control Regions (ICRs) that 
are usually associated with tandem arrays of transcription factor binding sites.  In the 
current study, the sequence features derived from a tandem array of YY1 binding sites of 
Peg3-DMR (differentially methylated region) led us to identify three additional clustered 
YY1 binding sites, which are also localized within the DMRs of Xist, Tsix, and Nespas.  
These regions have been shown to play a critical role as ICRs for the regulation of 
surrounding genes.  These ICRs have maintained a tandem array of YY1 binding sites 
during mammalian evolution.  The in vivo binding of YY1 to these regions is allele-
specific and only to the unmethylated active alleles.  Promoter/enhancer assays suggest 
that a tandem array of YY1 binding sites function as a potential orientation-dependent 
enhancer.  Insulator assays revealed that the enhancer-blocking activity is detected only 
in the YY1 binding sites of Peg3-DMR but not in the YY1 binding sites of other DMRs.  
Overall, our identification of three additional clustered YY1 binding sites in imprinted 
domains suggests a significant role for YY1 in mammalian genomic imprinting.
3Introduction
A subset of mammalian genes are subject to an unusual dosage control, genomic 
imprinting, by which one of two alleles of the genes are repressed in a parental-origin-
specific manner.  The imprinted genes are clustered in specific regions of chromosomes, 
and each imprinted domain is usually controlled by small genomic regions, termed 
Imprinting Control Regions (ICRs) (Brannan and Bartolomei, 1999; Spahn and Barlow, 
2003).  These ICRs are usually located in CpG-rich regions near the promoters of 
imprinted genes and methylated differentially between two parental alleles.  Surveys of 
the known ICRs indicated that these regions often show tandem repeat sequence structure 
and have evolved rapidly without any significant sequence conservation (Constancia et 
al., 1998; Reik and Walter, 1998).  Careful examinations of these ICRs revealed that the 
core sequences of these tandem repeats, ranging from 10 to 40 base pair (bp) in length, 
are conserved among different species, and that these conserved core sequences usually 
turn out to be transcription factor binding sites.  Known transcription factors binding to 
these tandem repeat regions include CTCF for the ICR of H19/Igf2 imprinted domain, 
and YY1 for the DMR of Peg3 (Bell and Felsenfeld, 2000; Hark et al., 2000; Kim et al., 
2003).  In the H19/Igf2 imprinted domain, CTCF has been shown to function as an 
enhancer-blocker for controlling allele-specific expression of H19 and Igf2 (Schoenherr 
et al., 2003; Fedoriw et al., 2004).  However, the in vivo functions of YY1 for the Peg3-
imprinted domain are currently unknown.    
YY1 is a Gli-Kruppel type zinc finger protein that controls the transcription of a 
large number of viral and cellular genes. YY1 can function as a repressor, activator, or 
transcriptional initiator depending upon the sequence context of YY1-binding sites with 
respect to other regulator elements (Thomas and Seto, 1999). The protein has a DNA-
binding domain at the C-terminus and other modulating domains at the N-terminus 
displaying repression, activation, and protein-protein interaction activities. YY1 interacts 
with several key proteins, including TBP, TAFs, TFIIB and Sp1 (Seto et al., 1993; Lee et 
al., 1993; Chiang et al., 1995; Usheva and Shank, 1994; Austen et al., 1997). Other 
studies have also indicated that YY1 recruits histone-modifying enzymes including p300, 
HDACs and PRMT1 to control transcription (Lee at al., 1995; Yang et al., 1996; Rezai-
Zadeh, 2003). YY1 is evolutionarily well conserved throughout all vertebrate lineages
4and at least two genes similar to vertebrate YY1 are found in fly genomes.  One of these 
YY1 homologues is known to be involved in the Polycomb complex-mediated repression
mechanism (Brown et al., 1998). In vertebrates, several studies also support the potential 
connection of YY1 to this heritable silencing mechanism (Satijn et al., 2001; Caretti et 
al., 2004).  YY1 is also thought to be involved in the formation of mammalian DNA 
repeat families based on the frequent detection of YY1 binding motifs in many families 
of different origin (Oei et al., 2004; Khan et al., 2006).
In contrast to known YY1 functions in cellular and viral genes, the function of 
YY1 in the Peg3-imprinted domain is expected to be very unique based on the 
localization of a tandem array of YY1 binding motifs within a genomic region 
undergoing an unusual epigenetic modification, allele-specific methylation. To gain 
insights for the functions of this tandem array of YY1 binding sites, we have sought to 
identify more regions with similar clustered YY1 binding sites in the current study.  With 
newly implemented strategies, we have identified 35 human and 21 mouse genomic 
regions with a tandem array of clustered YY1 binding sites.  We have characterized some 
of these potential regulatory regions, including clustered YY1 binding sites located 
within Xist, Tsix, and Gnas loci, in terms of their in vivo binding to YY1 as well as 
potential roles in transcription and imprinting.  The locations of clustered YY1 binding 
sites coincide with the Imprinting Control Regions (ICRs) of these domains, suggesting a 
significant functional role of these clustered YY1 binding sites in imprinting regulation.  
Result
Identification of clustered YY1 binding sites in ICRs
Two unique features observed from the clustered YY1 binding sites of Peg3-
DMR were used as searching criteria for finding potential new regulatory regions.  First, 
the YY1 binding sites of Peg3-DMR are all positioned in the same orientation.  Second, 
YY1 binding sites appear to be in an evolutionarily dynamic state, constant decay and 
regeneration, based on the observation that half of the YY1 binding sites within Peg3-
DMR have intact CpG sites while the remaining half have the mutated version of CpG 
sites (CpA or TpG) (Kim et al., 2003).  We have developed a PERL-based script that can 
identify clustered YY1 binding sites exhibiting these two features.  This program was 
5designed to first identify any genomic region that has more than two YY1 binding sites 
(CGCCATnTT; n indicates any base at that position) with the same orientation within a 
2-kb interval.  The initial pool of the selected genomic regions was further tested for the 
presence of a less stringent binding site (CCATnTT) without the CpG dinucleotide or a 
minor form of YY1 binding sites (ACATnTT) (Yant et al., 1995).  If the initial pool of 
the selected genomic regions had more than 3 YY1 binding sites at a density of one site 
per 300-bp genomic region, these genomic regions were selected for further 
investigation.  With these initial settings, we found 35 human and 21 mouse genomic 
regions that have tandem arrays of YY1 binding sites (Table 1 and Supplementary 
material).
Detailed examination of the mouse and human sets derived several interesting 
observations (Table 1).  First, the majority of these clustered YY1 binding sites (17/21) 
are derived from the first intron, exon, or promoter regions of individual genes, indicating 
the high success rate of our approach for finding potential regulatory regions.  This high 
success rate is partly due to the CpG-containing binding motif of YY1, since the 
promoters of mammalian genes tend to be associated with CpG-rich sequences.  Second, 
almost of all the clustered YY1 binding sites (19/20) show one particular orientation of 
YY1 binding sites relative to the transcriptional direction of their associated genes, while 
only one clustered YY1 binding site shows the other orientation.  A recent survey has 
also reported a similar orientation bias of YY1 binding sites relative to transcriptional 
direction, but the reason for this bias is not well understood to date (Schug et al., 2005).  
Third, although these genomic regions have been independently identified because of 
their unusual high densities of YY1 binding sites, half of these binding sites appear to 
represent the orthologous genomic regions of different species: nine regions between 
human and mouse and twelve regions between mouse and rat.  Most of these 
evolutionarily conserved YY1 binding sites show marginal sequence conservation 
between different species, ranging from 65 to 82% sequence identity. However, two 
YY1 binding sites located in the Peg3 and Xist locus show almost no sequence 
conservation beyond their YY1 binding sites, indicating that a tandem array of YY1 
binding sites is the only evolutionarily selected feature in these two regions (Table 1).
6Our screening criteria have been designed to identify genomic regions in a 
dynamic state of CpG methylation, decay and regeneration.  Some of the clustered YY1 
binding sites are indeed derived from the regions that are subject to constant DNA 
methylation as part of the epigenetic regulation of their associated genes.  Besides one 
known cluster in Peg3-DMR, three more clustered YY1 binding sites have been 
identified from such genomic regions, including the differentially methylated region of 
Nespas located in the Gnas imprinted domain (Fig. 1D), a small CpG island located 1-kb 
downstream of the Xist transcription start site, and a 1-kb tandem repeat region located in 
the 2nd intron of Tsix, which is also known as DXPas34 (DNA segment from 
chromosome X, Pastuer Institute 34; a Sequence Tag Site marker) (Fig. 1A).  The two 
clustered YY1 binding sites found in the Xist/Tsix locus are also localized within the 
CpG islands exhibiting differential methylation patterns between two parental alleles 
(Norris et al., 1994; Boumil et al., 2006) (Fig. 3C).  The 1.6-kb, Nespas-DMR harboring 
clustered YY1 binding sites has recently been shown to be the primary ICR for the Gnas-
imprinted domain (Williamson et al., 2006).
Evolutionary conservation of the YY1 binding sites in the Xist/Tsix and Nespas locus.
We analyzed the evolutionary conservation patterns of the clustered YY1 binding 
sites identified from the Xist/Tsix and Nespas loci (Fig.1).  The clustered YY1 binding 
site of mouse Xist has three potential YY1 binding motifs in the 400-bp genomic region, 
and the sequences of these three motifs are identical to the consensus sequence of known 
YY1 binding sites (CGCCATnTT).  In contrast, the same region of other mammals with 
similar length has more YY1 binding motifs: 8 in human, 7 in cow (Fig. 1B), and 8 in 
both horse and rabbit (GenBank accession Nos. U50911 and U50910).  The sequences of 
most YY1 binding motifs found in these species are also identical to the consensus 
sequence of known YY1 binding sites.  The consensus sequence of known YY1 binding 
sites (CGCCATnTT) shows no base preference at the 7th position, which is also well 
reflected in each of potential YY1 binding motifs located in the Xist cluster, showing all 
possible base choices at that position (Fig. 1B).  This position-specific, selective 
constraint on the potential YY1 binding motifs strongly suggests that these motifs have 
been selected for YY1 binding during evolution.
7The clustered YY1 binding site located in the 2nd intron of Tsix encompasses an 
1.1-kb tandem repeat region that is made of 32 reiterations of a core sequence, 34 or 35 
bp in length (Fig. 1C).  Our inspection of this core sequence identified two similar, but 
different, types of motifs, AGACATTTT and AGGCATTTT.  This region was initially 
identified due to the similarity between the first motif (AGACATTTT) to the minor form 
of known YY1 binding sites (ACATnTT).  The evolutionary conservation of these two 
motifs has been assessed through comparing the orthologous regions of mouse and rat, 
but not through mouse and other mammals, because the orthologous sequence of mouse 
Tsix is absent in other mammals.  The potential YY1 binding region of rat Tsix does not 
show any tandem repeat sequence structure, yet the two motifs appear to be the most 
obvious sequences that have been selected in this region (Fig. 1C).  
The clustered YY1 binding site located in the first intron of mouse Nespas 
harbors 7 potential YY1 binding motifs in a 1.7 kb-genomic region.  Three out of these 7 
potential motifs still contain a CpG dinucleotide within their binding motifs, which is 
also true for the orthologous region of rat Nespas (Fig. 1D).  In contrast, the orthologous 
human region was not initially identified as a clustered YY1 binding site with our 
searching criteria.  Our targeted examination of the human region, however, identified 5 
potential YY1 binding motifs with two of them showing one base difference to the 
minimal consensus sequence used for this search.  Also, none of these sites are associated 
with the CpG dinucleotide.  Further examination of this region in other mammals, such as
dogs and cows, revealed that the orthologous regions of other mammals contain much 
lower numbers of YY1 binding motifs, 1 or 2 motifs (data not shown).  Therefore, the 
evolutionary conservation of the clustered YY1 binding site of Nespas appears to be 
limited to rodents and possibly primates.  In sum, our comparative analyses revealed a 
rapidly evolving pattern in the clustered YY1 binding sites of Xist/Tsix and Nespas.  The 
only selected feature of these regions appears to be retention of multiple YY1 binding 
motifs.
Two divergent YY1 binding motifs in the Tsix cluster
The two motifs identified from the Tsix cluster were further analyzed in terms of 
their binding capability to YY1 using gel shift assays (Fig. 2).  For these experiments, we 
8used four sets of duplex oligonucleotides.  The two duplex probes, mYY1-1 and mYY1-
2, contain the first (AGACATTTT) and second (AGGCATTTT) motifs, respectively.  
These two probes were competed against two commercially available sets that have been 
designed for the YY1 gel shift assay.  The yy1 probe contains the consensus sequence of 
YY1 binding sites (CGCCATCTT), and thus allows YY1 binding with high affinity. In 
contrast, the yy2 probe has three base changes in the critical region of YY1 binding 
(CATTATCTT), and thus the YY1 protein cannot bind to the yy2 probe.  The first motif, 
mYY1-1, was tested with nuclear extracts prepared from HeLa cells (Fig. 2A, Lane 1-6).  
One protein complex binds to the mYY1-1 probe (Lane 2), and this binding was 
diminished when the yy1 probe was added for competition (Lane 3&4), but not with the 
yy2 probe (Lane 5&6).  This suggests that the protein complex binding to mYY1-1 may 
be YY1.  This was further confirmed with a supershift assay (Fig. 2C, Lane 1-3), in 
which the protein complex binding to mYY1-1 was mobility-shifted by anti-YY1 
antibody.  We repeated a similar set of experiments with the second probe, mYY1-2, 
which contains the second motif found in the Tsix cluster (Fig. 2A, Lane 7-12; Fig. 2C, 
Lane 4-6).  With similar results, the mYY1-2 probe appears to be a less favorable binding 
site for YY1 than the mYY1-1 probe based on the detection of weaker competition of the 
mYY1-2 probe against the yy1 probe (Fig. 2A, Lane 9&10) than the mYY1-1 probe (Fig. 
2A, Lane 3&4).  This conclusion was further confirmed through a set of reciprocal 
competition assays (Fig. 2B).  These several sets of gel shift assays demonstrate that the 
two evolutionarily conserved motifs found in the tandem repeat region of Tsix indeed 
have the capability to bind to YY1.
Allele-specific binding of YY1 to the Xist/Tsix, Peg3, and Nespas imprinted domains.
The in vivo binding of YY1 to the clustered YY1 binding sites was tested with 
Chromatin ImmunoPrecipitation (ChIP) assays using the neonatal brain tissues derived 
from two hybrid mice, F1 (female) and F2 (male).  Cross-linked chromatins were 
immunoprecipitated with polyclonal YY1 antibodies.  The precipitated DNAs were 
analyzed by PCR using multiple primer sets for each clustered YY1 binding site.  We 
have repeated our ChIP experiments more than 3 times for any given region, starting 
from ChIP to PCR, and one representative set is shown in the Figure 3 & 4.  As expected, 
9the enrichment by the YY1 antibody was detected in the Xist cluster but not in the 
surrounding regions (Fig. 3B).  Furthermore, this enrichment was detected mainly in the 
female tissue, while the enrichment was detected equally in both sexes at the autosomal 
Peg3 locus.  The Xist locus is active only in the inactive X (Xi) present in female 
mammals, whereas the Xist locus of the active X (Xa) present in both sexes is inactivated 
with methylation on the 5’-side CpG islands (Fig. 3C).  It has also been shown that YY1 
binding is methylation-sensitive (Kim et al., 2003).  Therefore, the female-specific 
enrichment by the YY1 antibody may be an indication that the YY1 binding to the Xist 
cluster is allele-specific, only to the unmethylated, active Xist locus present in Xi.  A 
similar set of ChIP assays were also performed on the second site, the Tsix cluster, with 
three primer sets (DXPas34; Fig. 3A).  However, due to the repetitive nature of this 
region, we have not been able to amplify this region efficiently and selectively.  
Therefore, the in vivo YY1 binding to the Tsix locus could not be confirmed from this 
study.  
Other clustered YY1 binding sites were also analyzed in terms of their in vivo
binding to YY1 (Fig.  4A).  Most of the clustered YY1 binding sites identified from our 
bioinformatic approach correspond to the in vivo binding sites of YY1, including the 
clusters in Rpl13a (ribosomal protein 13a), Ptbp1 (Polypyrimidine tract binding protein 
1), Sp1, Nr3C1 (Glucocorticoid receptor), Hcfc1 (Host cell factor C1) and three 
anonymous genes (AK220212, AK007485 and AK122447).  In contrast, the same ChIP 
experiments did not show any specific enrichment at other YY1-unrelated loci, such as 
H19-ICR and Igf2-DMR1 of the H19/Igf2-domain and IG-DMR of the Gtl2/Dlk1-
domain (Fig. 4A).  The two clustered YY1 binding sites located in the Peg3-DMR and 
Nespas-DMR are also proven to be the in vivo binding sites of YY1 (Fig. 4B&C).  
Among three primer sets targeting the Nespas locus, only the primer set amplifying the 
clustered YY1 binding site showed detectable levels of enrichment by anti-YY1 antibody 
(Fig. 4C), which is also true for the Peg3 locus (Fig. 4B).  Because these two clustered 
YY1 binding sites are located in differentially methylated regions, the allele-specific 
binding of YY1 was further tested at these two loci.  For these experiments, we used two 
hybrid mice, F1 (C3H x M. spretus) and F2 (F1 x M. musculus).  In F1 mice, the maternal 
allele is derived from M. musculus while the paternal is from M. spretus.  In F2 mice, 
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these two species alleles have been switched oppositely to two parental alleles.  To 
differentiate the two parental alleles, sequence polymorphisms were first identified 
between two parental species, and subsequently these polymorphisms were visualized 
with restriction enzyme digestions.  As shown in Fig. 4B&C, restriction enzyme 
digestions clearly demonstrated the presence of two alleles at the Input DNAs, but only 
one dominant allele in the YY1-immunoprecipitated DNAs that were derived from both 
F1 and F2 tissues.  This indicates that the immunoprecipitated DNA by the YY1 antibody 
was mainly derived from one of two parental alleles, in this case the paternal allele for 
both Nespas and Peg3.  
Transcriptional activity of clustered YY1 binding sites
Since most of clustered YY1 binding sites are localized close to the promoter 
regions of the associated genes, we analyzed the potential transcriptional activity of these 
sites.  For these experiments, we used the endogenous promoter regions that are 
associated with clustered YY1 binding sites to direct the transcription of two 
promoterless reporter genes, luciferase (pGL4, Promega) and IRES-b-Geo (Mountford et 
al., 1994).  In this scheme, the transcriptional involvement of the YY1 binding sites was 
determined by comparing the activities of the two types of reporter constructs: one with 
and the other without the YY1 binding sites.  We constructed a series of reporters with 
genomic fragments derived from mouse and human Xist, mouse Tsix, mouse Peg3, and 
mouse Nespas.  These constructs were transfected into several different cell lines (Fig. 5).
As shown in Fig. 5A, both human and mouse Xist contain two promoters and the 
second promoter region overlaps with the clustered YY1 binding site of Xist.  The 
activity of the first promoter of mouse Xist (Construct P1) was minimal with the pGL4 
reporter system in both Neuro2a and NIH3T3 cells, even lower than that of the ‘empty’ 
internal control (Construct pGL4), indicating no significant activity of this promoter with 
this reporter system.  However, when the second promoter (P2) of mouse Xist containing 
three YY1 binding sites was combined with the first promoter (P1), a genomic context 
similar to the endogenous one (Construct P1P2), this construct yielded 22-fold higher 
activity than the control vector.  This increased activity was detected only in the forward 
direction, indicating orientation-dependent increase of transcriptional activity by the P2 
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promoter.  Mutations on two of the three YY1 binding sites (CGCCAT.TT to 
CATTAT.TT) dramatically decreased the transcriptional activity in the forward direction 
(Construct P1mP2), confirming the direct involvement of YY1 in the promoter activity of 
Xist.  Another series of assays using the reporter system IRES-b-Geo also derived a 
similar conclusion that the inclusion of the YY1 binding sites increases the overall 
promoter activity of both mouse and human Xist (Constructs with b-Geo in Fig. 5A).  A 
similar pattern of results was also observed from the YY1 binding sites of mouse Tsix, 
boosting the transcriptional activity of promoters (data not shown).
The 2.5-kb clustered YY1 binding site of mouse Peg3 was also analyzed using 
constructs derived from the IRES-b-Geo system (Fig. 5B).  The promoter region of Peg3 
is bidirectional in vivo, directing the transcription of both Peg3 and Usp29, but only the 
constructs transcribing the reporter in the Peg3 direction showed transcriptional activity 
(Construct 1-4).  The constructs in the Usp29 direction showed no activity (Construct 
3R&4R).  The promoter without the YY1 binding sites (Construct 1) yielded some levels 
of transcriptional activity, but the inclusion of the YY1 binding sites resulted in the 
further increase of this activity. The constructs containing the 1.2-kb and 2.5-kb YY1 
binding sites yielded 2-fold and 4-fold more activity, respectively (Construct 2&3).  
When the 2.5-kb genomic region of multiple YY1 binding sites was positioned in the 
reverse orientation (Construct 4), the construct yielded very minimal levels of 
transcriptional activity, suggesting that the orientation of YY1 binding sites is critical for 
transcriptional activity.  
As compared to other YY1 sites, the YY1 binding motifs identified from Nespas 
are scattered evenly throughout the entire 1.7-kb genomic interval spanning from the 
promoter to first intron.  The promoter region with three YY1 binding motifs (Construct 
1) yielded relatively high transcriptional activity in both NIH3T3 and Neuro2A cell lines.  
However, the inclusion of the 1-kb first intron with the remaining 4 YY1 binding motifs 
(Construct 2) resulted in a dramatic decrease of the promoter activity.  Also, positioning 
the same region in an opposite orientation relative to that of the promoter further 
decreased the transcriptional activity of the Nespas promoter (Construct 3).  It remains to 
be investigated further, but the boosting effect observed consistently from other YY1 
binding sites suggests that this decrease may be due to the presence of unknown 
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repressors located within this interval, but not due to the addition of the four YY1 binding 
motifs.  Overall, our series of promoter assays on YY1 binding sites suggest that genomic 
regions with multiple YY1 binding sites function as potential enhancers with orientation 
dependency.
Insulator activity of clustered YY1 binding sites 
Since our initial observation on the clustered YY1 binding sites of Peg3-DMR 
revealed the presence of enhancer-blocking activity in the region (Kim et al., 2003), a 
series of similar insulator assays were performed to determine if the clustered YY1 
binding sites identified in this study also have enhancer-blocking activity (Fig. 6).  For 
these experiments, we used a cell line-based assay system utilizing a construct, pNI-CD, 
which contains the Neomycin resistance gene (NeoR) as a reporter under the control of 
the erythroid-specific enhancer and promoter with a testing DNA fragment being 
positioned between this enhancer and promoter (Chung et al., 1997; Bell et al., 1999; Fig. 
6B).
Consistent with the human Peg3-DMR (Kim et al., 2003), the clustered YY1 
binding sites of mouse Peg3-DMR also showed similar enhancer-blocking activity with 
the forward direction being more obvious, suggesting the evolutionary conservation of 
this activity in both species (mPeg3-1F).  However, the clustered YY1 binding sites 
derived from both Xist and Tsix showed an unexpected, opposite outcome.  The clustered 
YY1 binding sites of Xist and Tsix from mouse (mXist and mTsix), human (hXist), 
bovine (bXist), and rat (rTsix) all yielded much higher numbers of surviving colonies 
than the control construct without an insulator, pNI-CD(-AscI).  This increase was 
observed in both orientations of the clustered YY1 binding sites.  This is very unusual 
because any given DNA fragment without insulator activity, such as l DNA fragments, 
usually yields either similar or slightly lower numbers of surviving colonies than the pNI-
CD(-AscI) construct (Bell et al., 2000; Hark et al., 2000).  As an independent measure to 
resolve the two different outcomes between the YY1 clusters of Peg3-DMR versus the 
Xist/Tsix locus, we tested two unrelated DNA fragments containing a tandem array of 
YY1 binding sites: one 1.2-kb DNA fragment derived from one type of mouse LINE 
(mL1) and a 800-bp DNA fragment derived from the last intron of human fibrulin 1 gene 
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(FVB).  Both fragments also showed a similar result, the increased numbers of surviving 
colonies, suggesting that multiple YY1 binding sites be responsible for the observed 
increase.  This is quite different from the enhancer-blocking activity observed from the 
YY1 sites of Peg3-DMR (Kim et al., 2003).  It remains to be studied further in the future, 
but these results suggest that clustered YY1 binding sites may not function as an 
enhancer-blocker, and that the insulator activity observed from the clustered YY1 binding 
sites of Peg3-DMR may be a locus-specific activity.  
Discussion
The clustered YY1 binding site of the Peg3-DMR region led us to identify three 
additional clustered YY1 binding sites that are localized in genomic regions undergoing 
similar epigenetic regulation as Peg3, the DMRs of Xist, Tsix, and Nespas.  These 
genomic regions have maintained a tandem array of YY1 sites throughout mammalian 
evolution.  The YY1 binding to these regions except for Tsix is shown to be allele-
specific and only to the unmethylated, active allele of the regions.  The promoter and 
insulator assays also suggest that these regions function as a potential transcriptional 
enhancer but not as an enhancer-blocker.
Our screening strategy with the features derived from the Peg3-YY1 binding sites 
has been successful for finding additional ICRs as clustered YY1 binding sites.  Four out 
of 21 clustered YY1 binding sites in mouse turn out to be ICRs, which is an unusual 
enrichment given the sheer number difference between imprinted and non-imprinted 
genes (~ 100 to 40,000 per each mammalian genome).  An independent study also 
reported the unusual enrichment of a particular sequence motif in imprinted domains,  
(Motif 13: GGCCTGCCCTCCATCTTAG), which also appears to contain the minimal 
core motif of YY1 binding sequences (Wang et al., 2004).  This frequent occurrence of 
YY1 binding sites in imprinted domains may be related to the two unique features of 
YY1.  First, YY1 binding to its CpG-containing binding site (CGCCAT.TT) is 
methylation-sensitive and thus can be controlled by the CpG methylation (Kim et al., 
2003).  This controllable binary mode of the YY1 binding to DNAs is an ideal feature for 
ICRs, which are predicted to regulate allele-specific involvement of trans factors.  This 
has been further demonstrated in vivo in the current study showing the allele-specific 
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binding of YY1 to Xist, Nespas, and Peg3 (Fig. 3&4).  Second, in Drosophila, YY1 is 
one of DNA-binding proteins responsible for the targeting of the Polycomb complex 
(Brown et al., 1998).  The stable and heritable repression mediated through the Polycomb 
complex is similar, in many ways, to that of genomic imprinting.  In fact, mammalian 
Polycomb complexes have been shown to be involved in maintaining the repressed state 
of imprinted domains (Mager et al., 2003; Lewis et al., 2004; Umlauf et al., 2004).  
Several studies also suggest that mammalian YY1 plays a similar role as shown in 
Drosophila as a targeting (or recruiting) protein of the Polycomb complexes (Caretti et 
al., 2004; Srinivasan et al., 2005).  Thus, the unusual enrichment of YY1 binding sites 
may be for the targeting of the Polycomb complexes to the imprinted domains.  In a 
similar line, it is interesting to note that the clustered YY1 binding sites of Peg3, Xist, 
Tsix, and Nespas all inherit their DNA methylation as a gametic signal from the previous 
generation (Norris et al., 1994; Lucifero et al., 2002; Coombes et al., 2003; Boumil et al., 
2006).  This suggests that YY1 and mammalian Polycomb complexes may be also 
involved in establishing imprinting signals on these ICRs during gametogenesis.  
Most clustered binding sites are localized very close to promoters or 1st introns of 
genes (Table 1), suggesting that multiple YY1 binding sites are closely related to some 
unknown aspects of transcription.  Consistently, the multiple YY1 binding sites of Peg3, 
Xist and Tsix appear to increase the transcriptional strength of their promoters (Fig. 5).  
This also agrees well with the results of recent studies on the Tsix promoter, revealing 
that the YY1 binding sites in Tsix, DXPas34, have enhancer-like functions (Debrand et 
al, 1999; Stravropoulos et al., 2005).  This region does not function as an independent 
enhancer, but some other upstream enhancers require this region for their transcriptional 
activation.  The multiple YY1 binding sites also show an unusual orientation bias relative 
to gene’s transcriptional direction (Table 1).  The reason for this bias is not well 
understood, but may be related to earlier observations regarding YY1 functions (Natesan 
and Gilman, 1993; Kim and Shapiro, 1996).  These studies indicated that YY1 has an 
unusual DNA-bending capability and also that this bending activity is required for the 
transcription of the associated genes.  The potential involvement of YY1 in the bending 
of DNA or chromatin structure is well supported, particularly, by the multiplicity of YY1 
binding sites.  It is easily conceivable that multiple binding sites with one particular 
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orientation may be necessary for the bending of relatively large-size DNAs or chromatin 
of promoter regions.
The tandem arrays of YY1 binding sites derived from Xist, Tsix, and two other 
genomic loci do not have enhancer-blocking activity.  This differs from the multiple YY1 
binding sites of Peg3-DMR.  According to the results from our insulator assays (Fig. 6), 
the multiple YY1 binding sites tend to derive an opposite outcome as expected from 
typical enhancer-blockers, resulting in more surviving colonies than the control vector.  
In this colony assay system, the boosted colony number could be caused by either 
increased transcriptional strength and/or increased protection from becoming 
heterochromatin.  It is currently unclear which of these may contribute to the increased 
colony survivability, nevertheless the ultimate functional contribution by these multiple 
YY1 binding sites appears to be boosting or maintaining transcription of nearby genes.  
This is also consistent with the potential enhancer activity detected in the multiple YY1 
binding sites of Peg3, Xist, and Tsix (Stravropoulos et al., 2005; Fig. 5). If the in vivo
function of multiple YY1 binding sites is indeed a transcriptional enhancer, the potential 
imprinting control mechanism(s) mediated by these ICRs may be different from the 
current enhancer-blocking model suggested from the H19/Igf2 domain (Wolffe, 2000; 
Bell et al., 2001).  The simplest model would be similar to the original enhancer 
competition hypothesis (Bartolomei and Tilghman, 1997; Brannan and Bartolomei, 
1999).  The ICRs with multiple YY1 binding sites in an unmethylated allele provide 
dominant transcriptional strength to immediate neighbor genes due to their proximity 
and/or compatibility, whereas in a methylated inactive allele the surrounding genes 
located in farther genomic distances can be transcribed due to the inactive state of the 
dominant genes.  It needs to be tested in the future, but the ICRs with a tandem array of 
YY1 binding sites are predicted to provide new paradigm(s) for imprinting regulatory 
mechanism.   
 
Methods
Identification of clustered YY1 binding sites
To test and optimize our bioinformatics searches, we performed a series of 
pretests, including Position Weight Matrix-based searches using more generous and 
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statistical methods.  One of main lessons from these pretests was that many genomic 
regions could be easily identified as potential clustered YY1 binding sites with the total 
number of positive hits per each genome ranging from several hundreds to thousands.  In 
particular, many positive hits turned out to be associated with repetitive DNA elements in 
both human and mouse.  Therefore, we decided to perform more stringent searches using 
masked genome sequences.  We also decided to perform more focused searches targeting 
evolutionarily dynamic regions with constant decay and regeneration of the CpG 
dinucleotide.  All the lessons learned from the pretests have been incorporated into the 
final version of our homemade PERL script.  Using this script, we have analyzed the 
masked genome sequences of human (hg17), mouse (mm5), and rat (rn3).  The identified 
genomic regions were mapped and annotated using the BLAST and Mapviewer 
programs.  The PERL script and the sequences of the identified clustered YY1 binding 
sites can be available upon request.
Gel shift assay
The Gel Shift Assay system (Promega, Madison, WI) was used for our DNA 
mobility shift assays.  About 4 mg of nuclear extracts were first mixed with binding 
buffer and unlabeled competitor probes with varying amounts (10 to 100 pico moles) for 
20 minutes at room temperature and later mixed with the P32-labeled duplex probes (1 
pico mole) for additional 10 minutes at room temperature.  The reaction mixtures were 
separated on 5% native polyacrylamide gel (acryl:bis=37.5:1) in 0.5X Tris buffer at pH 
8.0 for 2 hours, and the separated gels were exposed to X-ray films for 1 hour.  For 
supershift assays, the polyclonal antibody raised against the entire portion of human YY1 
was obtained from a commercial firm (Catalogue No. sc-1703; SantaCruz Biochem, 
Santa Cruz, CA).  Another polyclonal antibody raised against histone H3 was also used 
as a negative control for supershift assays (Catalog No. sc-10809; SantaCruz Biochem, 
Santa Cruz, CA).  All the gel shift assays used nuclear extracts prepared from human 
HeLa cell lines (Promega, Madison, WI).  The following oligonucleotides are the probes 
for our gel shift assays: mYY1-1 (5’-CCCCGTGGCAGACATTTTAGTGACCTCCCA-
3’, 5’- TGGGAGGTCACTAAATGTCTGCCACGGGG-3’); MYY1-2 (5’-
CCCCGTGGCAGGCATTTTAGTGACCTCCCA-3’, 5’-
17
TGGGAGGTCACTAAAATGCCTGCCACGGGG-3); yy1 (5’-
CGCTCCGCGCCATCTTGGCGGCTGGT-3’, 5’-
ACCAGCCGCCAAGATGGCGCGGAGCG-3’); yy2 (5’-
CGCTCCGCATTATCTTGGCGGCTGGT-3’, 5’-
ACCAGCCGCCAAGATAATGCGGAGCG-3’). 
Chromatin ImmunoPrecipitation (ChIP) assay 
Chromatin immunoprecipitations were performed according to the protocol 
provided by Upstate Biotechnology (Upstate Biotech., NY, NY) with some modification 
as described previously (Kim et al., 2003). Briefly, we used mouse brain tissues from 
neonatal F1 (C3H x Mus spretus) and F2 (F1 x Mus musculus) hybrid homogenized in 
10ml PBS for ChIP assay. The samples were treated with formaldehyde to final 
concentration of 1% and incubated at 37oC for 10 min. Treated samples were sheared by 
sonication and immunoprecipiated with anti-YY1 antibody. Precipitated DNA and 
protein complexes were reverse cross-linked and purified through phenol/chloroform
extraction. Purified DNA was used as templates for PCR amplification. The 
oligonucleotide sequences used for this study can be available upon request.  PCR 
reactions were carried out for 36 cycles using standard PCR conditions. The resulting 
PCR products were analyzed by running on 1.6% agarose gel and staining with ethidium 
bromide. 
Promoter/Enhancer assay
The 5.1-kb IRES-b-Geo fragment was transferred from the pGT1.8IresBgeo 
vector (Mountford et al., 1994) into the BamHI site of pBluescript SK(-).  Genomic 
fragments containing a tandem array of YY1 binding sites were amplified by PCR, and 
subcloned into the NotI site of the modified pBluscript with IRES-b-Geo.  For the 
reporter assays with the pGL4 system, the promoter and YY1 binding sites of Xist were 
subcloned into the BglII and HindIII sites, respectively, whereas the promoter and first 
intron of Nespas into XhoI and BglII sites.  The locations of the tested DNA fragments 
within the GenBank accession Nos. are as follows: Peg3 Construct 1 (AF105262; 2110-
3379), Construct 2 (AF105262; 2110-4281), Construct 3 (AF105262; 2110-5905), mouse 
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Xist Construct P1 (AJ421479; 105154-107233), Construct P1P2 (AJ421479; 105154-
108089), human Xist Construct hP1 (AL353840; 37006-35218), hP1P2 (AL353840; 
37006-34435), mouse Tsix Construct 1 (AJ421479; 140222-141899), Construct 2 
(AJ421479; 138971-141899), and mouse Nespas Construct 1 (AJ251761; 13753-12730), 
Construct 2 (AJ251761;12731-11797).   
For the promoter/enhancer assays, HEK 293, NIH 3T3 and HeLa cells were 
grown in DMEM medium (Gibco BRL, Rockville, MD) and Neuro2A cell was 
maintained in MEM medium (Gibco BRL, Rockville, MD).  Media were supplemented 
with 10% fetal bovine serum and 1% antibiotic-antimycotic (Gibco BRL, Rockville, 
MD).  All cell lines were grown at 37oC in a humidified incubator containing 5% CO2. 
The 2×105 cells were plated per one well of six-well plate.  On the next day, cells were 
cotransfected with GeneJuice transfection reagent (Novagen, Madison, WI) according to 
the manufacturer’s protocol.  Briefly, transfection was performed with serum-free 
medium containing 3 ml of GeneJuice and 1 mg of DNA (0.9mg b-Geo vector + 0.1mg
pGL3 Control vector (Promega, Madison, WI)) per well.  Two days after transfection, the 
cells were harvested, washed with PBS, and treated with 200 ml of lysis buffer (0.25M 
Tris-HCl, pH 7.8 + 0.1% NP40) for 30 min at 4oC and cellular debris was removed by 
centrifugation for 10 min.  For the b-galactosidase assay, 30 ml of cell lysate was mixed 
with same volume of 2x b-galactosidase assay buffer (Promega, Madison, WI) in a 96-
well flat-bottom clear plate.  The plate was incubated at 37oC, monitored visually and 
terminated with 90 ml of 1M sodium carbonate.  The absorbance was measured at 405 nm 
with Wallac 1420 multilabel counter VICTOR3 (PerkinElmer, Boston, MA).  To control 
for transfection efficiency in each well, b-galactosidase activity was normalized to 
luciferase activity. For the luciferase assay, 20 ml of cell lysate was combined with 100 
ml of Luciferase Assay Reagent in a 96-well flat-bottom white plate (Corning, Corning, 
NY).  Luminescence was measured with Wallac 1420 multilabel counter VICTOR3.  
Insulator assay
DNA fragments of interest were cloned into the AscI site of pNI-CD (generous 
gift from Drs. Gary Felsenfeld and Adam West).  Each fragment was cloned in both 
orientations.  The locations of the tested DNA fragments within the GenBank accession 
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Nos. are as follows: mPeg31-1 (AF105262; 1984-2932), mXist (AJ421479; 105842-
107855), hXist (M97168; 1186-1710), bXist (AF104906; 945-1644), mTsix (AJ421479; 
138971-140246), rTsix (NW_048043.1; 2951903-2953005), and FVB (NT_086921.1; 
23995819-23996257).  The mL1 was amplified from the BAC clone, RPCI23-93H2, with 
the following two primers: mL1-a (5’-GGCCTAGTCAGCCATCATTGG-3’) and mL1-b 
(5’- TTACAGGGAAGGTGCGCAGA-3’).  Constructs were transfected into K562 cells 
by electroporation at 200V, 1000 mF (double pulse) using a Bio-Rad Gene Pulser II.  
After a 10 minute recovery on ice, cells were plated into RPMI supplemented with 10% 
FBS, 200mM L-glut and Pen/Strep.  Twenty-four hours post transfection, cells were 
washed and resuspended in Improved MEM Zn++ option (GibcoBRL, Rockville, MD).  
Cells were plated into 0.3% soft agar with 1050 mg/ml Geneticin (GibcoBRL, Rockville, 
MD) and incubated at 37oC for 18-21 days.
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Figure legends
Fig. 1.  Three clustered YY1 binding sites located in the Xist/Tsix and Nespas loci.  
A) The genomic structure of the Xist/Tsix locus. The arrows indicate the direction of 
Xist and Tsix transcription, and each gene has two different transcription start sites.  The 
arrowheads indicate the positions of two clustered YY1 binding sites.  B-C) The 
conservation patterns of two clustered YY1 binding sites, the Xist cluster and the Tsix 
cluster.  The two divergent motifs found in the Tsix clusters are marked: one with an 
underline and the other without an underline.  D) The genomic structure of the Gnas-
imprinted domain and the conservation patterns of the clustered YY1 binding site located 
in the 1st intron of Nespas.  The YY1 binding motifs associated with a CpG dinucleotide 
are underlined.  The nucleotide bases are bold-typed if the sequences of each binding 
motif are identical to the consensus sequence of known YY1 binding sites.
Fig. 2.  DNA mobility shift assays of two divergent motifs of the Tsix cluster. A) The 
two motifs found in the Tsix cluster, AGACATTTT (mYY1-1) and AGGCATTTT 
(mYY1-2), were labeled as probes for gel shift assays.  Each of two commercially 
available YY1 oligonucleotides, yy1 and yy2, were used as a competitor at two different 
molar ratios relative to a given probe (10x, Lane 3 & 9; 100x, Lane 4 & 10).  B) Another 
series of the reciprocal competition assays using yy1 as a labeled probe were also 
performed.  In this assay, the molar ratios of mYY1 and mYY2 to the labeled yy1 probe 
are 10x (Lane 3 & 6), 25x (Lane 4 & 7), and 100x (Lane 5 & 8), respectively.  C)
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Supershift assays were performed using two polyclonal antibodies, anti-YY1 antibody 
and anti-H3 antibody as an unrelated negative control.  The sequences of the four duplex 
oligonucleotide probes are shown at the bottom.  The two motifs of the Tsix locus are 
positioned in the middle of these probes and marked with underlines.  The nucleotide 
positions differing from the consensus sequence of YY1 binding sites are also indicated 
with bold types.   
Fig. 3.  Allele-specific binding of YY1 to the Xist and Tsix clusters.  A) The in vivo
YY1 binding to each cluster was tested with three primer sets, and the positions of these 
are indicated with arrows with numbers.  B) Female-specific binding of YY1 to the Xist 
cluster.  Two mouse brain tissues from female (F1) and male (F2) were used for our ChIP 
experiments.  Our ChIP analyses included two control DNAs: 10% of the Input DNAs 
from F1 (Lane 1) and F2 (Lane 4) and the immunoprecipitated DNA with pre-immune 
serum (Lane 2 & 5).  Our ChIP analyses used the Peg3 locus as an internal control for 
female- and male-derived ChIP DNAs as shown in the bottom.  C) Schematic 
representation of allele-specific YY1 binding to the Xist locus based on the results of (B). 
YY1 binds to the Xist cluster located in the Xi of female, which is unmethylated.  Due to 
the repeat structure of the Tsix cluster, however, our ChIP analyses could not confirm the 
in vivo YY1 binding to this locus.  The methylation status of Tsix reflects the gametic 
difference between two sexes before the onset of random XCI (X chromosome 
inactivation).  For the imprinted XCI in female, Xa is from oocytes (maternal) while Xi is 
from sperm (paternal).    
Fig. 4.  In vivo YY1 binding to other clustered regions.  YY1 binding was tested on 
other clustered YY1 binding sites listed in Table 1.  This series of ChIP analyses were 
also performed on three non-YY1 binding sites as negative control loci, including H19-
ICR, Igf2-DMR1, and IG-DMR.  The amplified PCR products of each cluster are shown 
in the following format: 10% of the Input DNA from F1 (Lane 1), with pre-immune 
serum (Lane 2), F1 brain (Lane 3) and F2 brain (Lane 4) with anti-YY1 antibody.  We 
determined the allelic origin of the YY1-immunoprecipitated DNAs from the clustered 
site in B) Peg3-DMR and C) Nespas-DMR.  This analysis utilized sequence 
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polymorphisms detected between the two parental species of our hybrid mice, F1 and F2.  
The restriction enzymes differentiating these sequence polymorphisms are shown with 
the estimated sizes of digested PCR products for each species.  Two separate restriction 
enzyme digestions clearly demonstrated the presence of two alleles in the Input DNAs of 
F1 (Lane 1).  However, the YY1-immunoprecipitated DNAs at both Peg3-DMR and 
Nespas-DMR were mainly derived from the paternal allele (Lane 3 & 4).
Fig. 5.  Transcriptional activity of the clustered YY1 binding sites.  The 
transcriptional involvement of each clustered YY1 binding site was tested together with 
its endogenous promoter using pGL4 and/or IRES-ß-Geo promoterless vector systems.  
A) Transcriptional activity of YY1 binding sites of mouse and human Xist.  The 
schematic diagram represents the genomic layout of two promoters with three YY1 
binding sites of mouse Xist.  Five constructs with one internal control (pGL4) were used 
for the analyses of the two promoters of mouse Xist, P1 and P2.  The values shown in the 
graph on the right side represent the averaged fold difference with standard deviation 
compared to that of the internal control.  Each construct was analyzed more than three 
times using different cell lines shown inside a parenthesis.  Since the overall patterns of 
data were similar among different cell lines, the graph shows only one representative data 
set from one of these cell lines, the name of which is underlined.  The four constructs on 
the bottom represent the constructs of mouse and human Xist using another vector 
system, IRES-ß-Geo. Two other YY1 binding sites were also analyzed in a similar way: 
the YY1 binding sites of mouse Peg3 B) and mouse Nespas C).  In the case of constructs 
derived from IRES-ß-Geo, the empty control vector does not yield any activity at all, and 
thus the vector construct containing each promoter without YY1 binding sites was used 
as an internal control.
Fig. 6.  Insulator assay of the clustered YY1 binding sites.   For insulator assays, the 
testing DNA fragments were positioned between an erythroid-specific enhancer (Enh) 
and promoter directing the transcription of a reporter, NeoR, as shown in B).  This test 
used two control vectors: pNI-CD(-AscI) without any insulator and pNI-CD with a 
chicken insulator.  The genomic fragments containing clustered YY1 binding sites were 
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subcloned into the AscI site of the pNI-CD vector with two different orientations, forward 
(-F) and reverse (-R).  The DNA fragments for the clustered sites of Xist and Tsix were 
derived from mouse (m), human (h), cow (b), and rat (r).  Each fragment was tested more 
than three times, and the averaged values with standard errors are shown in A).  The 
overall patterns observed in this series of experiments are summarized schematically in 
B) with averaged values shown below the name of each construct.
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Table 1. Summary of clustered YY1-binding sites in mouse, human and rat genomes.
Position in
Chromosome (Mus)
YY1 sites
(length)
Associated 
genes
Position
within gene
Relative 
orientation
YY1 sites
in Human
YY1 sites 
in Rat
chr2_066036052 4 (156) Ttc21b 3’-side -
chr2_173719220 7 (1772) Nespas 1st intron - 5 (1000) b 7 (1612)
chr3_114925409 4 (126) AK033312.1 1st intron -
chr4_069501498 4 (464) Cdk5rap2 promoter - 4 (462)
chr4_148302389 25 (1184) hmm34352 a promoter -
chr5_133277986 6 (204) intergenic
chr6_090805714 3 (210) BC003332 1st exon - 3 (370)
chr7_004262378 3 (596) AK220212 promoter - 3 (360)
chr7_005929953 14 (3176) Peg3 1st intron + 13 (3512) 14 (3176)
chr7_039205106 3 (582) Rpl13a promoter - 4 (696)
chr10_079976775 3 (272) Ptbp1 promoter - 4 (266) 3 (360)
chr11_075458625 3 (806) Ywhae 1st intron - 3 (796) 3 (794)
chr11_095050393 3 (426) XM_488607 1st intron -
chr15_102465517 3 (648) Sp1 promoter -
chr16_008502921 3 (398) AK007485 1st intron - 4 (744) 3 (398)
chr16_089247383 3 (400) NM_026064 2nd exon -
chr18_039715389 3 (430) Nr3c1 1st intron - 3 (450)
chrX_068626364 6 (1144) Hcfc1 1st exon - 6 (1800) 6 (1144)
chrX_098049096 25 (2348) Tsix 2nd intron - 10 (1190)
chrX_098083018 3 (436) Xist 1st exon - 8 (714) 3 (436)
chrX_145054819 4 (364) AK122447 promoter - 4 (420) 4 (362)
a: This is a predicted gene based on ESTs and homology evidence. 
b: The human region was not recognized with our initial criteria, but our targeted manual 
inspection identified 5 potential YY1 binding sites within the 1-kb human region.
